Search

everythinglearnresearchcommunity

for

Search:↓

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Lasers and light sources can effectively remove hair, work best on fair skin with dark hair, and usually need multiple treatments.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Advanced human skin models improve drug development and could replace animal testing.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Human hair follicle cells can be turned into stem cells similar to embryonic stem cells.

Improving the environment and cell interactions is key for creating human hair in the lab.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Combining LFQS and IPL is more effective and faster for treating melasma than LFQS alone.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Laser and light treatments offer quick, long-lasting hair removal for large areas.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Both intense pulsed light and long-pulsed diode laser effectively reduced facial hair in women, with no significant difference in satisfaction after 6 months, but intense pulsed light was more painful.

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

Topical cream eflornithine 11.5% can slow hair growth and may help reduce hair removal frequency.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Future clinical uses of Intense Pulsed Light (IPL) are likely to grow and become more effective with new advancements and combined treatments.

Eflornithine cream slows facial hair growth and works well with other treatments.

Skin organoids are a promising new model for studying human skin development and testing treatments.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Human hair follicle cells can be successfully transformed into different types of cells, but not more efficiently than other adult cells.

Stem cell-derived organoids can improve skin healing.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.